Knobbe Martens Intellectual Property Law - Biotechnology
Our firm boasts IP law’s largest and most experienced biotechnology
group, with more than 60 attorneys and scientists representing clients
in all stages of their business and technology development. Our
clients are innovators in a variety of disciplines including PCR,
molecular tools and probes, immunology (antibodies and other binding
proteins), cell varieties and uses (including stem cells) and
biological polymers, to name but a few. Our expertise across the
entire biotech landscape gives us great insight into specific
technologies, systems and markets. More importantly, our holistic
understanding of the interrelated technologies and systems typically
involved in a single invention allows us to provide coordinated
guidance and counsel from inception though introduction. Working in
collaboration with more than 300 IP firms worldwide, we effect patent,
trademark, copyright, and other filings, and direct oppositions,
cancellations, and litigation matters in over 120 countries. We have
considerable experience in negotiating and drafting traditional
licensing agreements as well as agreements for strategic alliances,
partnerships and joint ventures. We also maintain a talented
litigation department adept in all aspects of biotechnology IP law,
including the Biosimilars legislation. Our extensive Hatch-Waxman
litigation experience combined with our understanding of the
biotechnology industry uniquely positions Knobbe Martens to help
clients develop and implement litigation strategies designed to
maximize their place in the Biosimilars market place. In addition, we
have considerable experience litigating before the U.S. Court of
Appeals for the Federal Circuit and the International Trade
Commission. Our attorneys have experience in all areas of
Biotechnology, including: Aesthetic & Cosmetic Biotechnology
Antibodies & Immunology Biofuels Biological Manufacturing Of Chemicals
Biologics Diagnostic Tools Genomics Industrial Enzymes Peptides
Personalized Medicine Research Tools & Reagents Stem Cells &
Regenerative Medicine Synthetic Biology & Nanotechnology Therapeutics
Tissue Engineering Transgenic Animals Vaccines
